DLBCL Treatment Roadmap: R-CHOP, Relapsed Lymphoma, CAR T-Cell Therapy and Bispecific Antibodies

This oncology lesson details DLBCL Treatment Roadmap from First-Line Therapy to CAR-T with a focused overview of diffuse large B-cell lymphoma, R-CHOP chemotherapy, and DLBCL relapse. The presentation connects CAR T-cell therapy, bispecific antibodies, and lymphoma treatment, with practical context for diagnosis, treatment sequencing, expected outcomes, and follow-up. The video is especially relevant to people searching for diffuse large B-cell lymphoma, CAR T-cell therapy, or bispecific antibodies and wanting a clearer explanation of how oncologists make treatment decisions. Useful for learning how modern cancer care combines imaging, pathology, systemic therapy, surgery, radiation, and supportive care. Modern oncology often uses multidisciplinary